GLAXOSMITHKLINE, OXFORD UNIVERSITY FORM INDIAN CANCER RESEARCH VENTURE

GlaxoSmithKline PLC and Britain's Oxford University have formed a cancer research venture in India to establish a cancer-trials network in the country. India's leading senior oncologists at major cancer centres will work with the university and company, evaluating new treatments in a range of cancer types which are more prevalent in India than in Europe or North America.

Forbes (http://www.forbes.com/markets/feeds/afx/2005/11/17/afx2343205.html)